dc.contributor.author | Selli, Anders Lund | |
dc.contributor.author | Ghasemi, Mohammadreza | |
dc.contributor.author | Watters, Taylor | |
dc.contributor.author | Burton, Francis | |
dc.contributor.author | Smith, Godfrey L | |
dc.contributor.author | Dietrichs, Erik Sveberg | |
dc.date.accessioned | 2023-11-14T08:40:36Z | |
dc.date.available | 2023-11-14T08:40:36Z | |
dc.date.issued | 2023-10-25 | |
dc.description.abstract | Background Accidental hypothermia, recognized by core temperature below 35 °C, is a lethal condition with a mortality rate up to 25%. Hypothermia-induced cardiac dysfunction causing increased total peripheral resistance
and reduced cardiac output contributes to the high mortality rate in this patient group. Recent studies, in vivo
and in vitro, have suggested levosimendan, milrinone and isoprenaline as inotropic treatment strategies in this
patient group. However, these drugs may pose increased risk of ventricular arrhythmias during hypothermia. Our aim
was therefore to describe the efects of levosimendan, milrinone and isoprenaline on the action potential in human
cardiomyocytes during hypothermia.<p>
<p>Methods Using an experimental in vitro-design, levosimendan, milrinone and isoprenaline were incubated
with iCell2
hiPSC-derived cardiomyocytes and cellular action potential waveforms and contraction were recorded
from monolayers of cultured cells. Experiments were conducted at temperatures from 37 °C down to 26 °C. Oneway repeated measures ANOVA was performed to evaluate diferences from baseline recordings and one-way
ANOVA was performed to evaluate diferences between drugs, untreated control and between drug concentrations
at the specifc temperatures.
<p>Results Milrinone and isoprenaline both signifcantly increases action potential triangulation during hypothermia,
and thereby the risk of ventricular arrhythmias. Levosimendan, however, does not increase triangulation and the contractile properties also remain preserved during hypothermia down to 26 °C.
<p>Conclusions Levosimendan remains a promising candidate drug for inotropic treatment of hypothermic patients
as it possesses ability to treat hypothermia-induced cardiac dysfunction and no increased risk of ventricular arrhythmias is detected. Milrinone and isoprenaline, on the other hand, appears more dangerous in the hypothermic setting. | en_US |
dc.identifier.citation | Selli AL, Ghasemi, Watters, Burton F, Smith GL, Dietrichs ES. Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2023;31(1) | en_US |
dc.identifier.cristinID | FRIDAID 2188660 | |
dc.identifier.doi | 10.1186/s13049-023-01134-5 | |
dc.identifier.issn | 1757-7241 | |
dc.identifier.uri | https://hdl.handle.net/10037/31748 | |
dc.language.iso | eng | en_US |
dc.publisher | BMC | en_US |
dc.relation.journal | Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2023 The Author(s) | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | en_US |
dc.rights | Attribution 4.0 International (CC BY 4.0) | en_US |
dc.title | Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |